Opportunity Information: Apply for RFA DA 19 014
This funding opportunity aims to foster the development and assessment of digital technologies that use loyalty and reward systems to enhance adherence to pharmacotherapies for substance use disorders. The initiative is structured in two phases.
In Phase I (R43), the focus is on testing the feasibility and validation of the technology. Phase II (R44) shifts to evaluating the effectiveness of the reward-based platform with a larger group of participants. The main goal is to improve adherence to FDA-approved medications for substance use disorders while ensuring that the reward system is self-sustaining. An important feature is that treatment providers should have access to a front-end interface to monitor patient progress and deliver rewards effectively.
The platforms may incorporate innovative tools such as automated tracking, real-time patient assessments, and monitoring of medication intake. The results gathered from these studies will support a 510k submission for FDA clearance as a medical device. Eligible applicants exclude foreign entities, including components of U.S. organizations based abroad, though some foreign components may be permissible as per NIH guidelines.Apply for RFA DA 19 014
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Loyalty and Reward-Based Technologies to Increase Adherence to Substance Use Disorder Pharmacotherapies (R43/R44 - Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279.
- This funding opportunity was created on 2018-09-18.
- Applicants must submit their applications by 2018-12-14. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2025.)
- Eligible applicants include: Small businesses.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Education, Health
Next opportunity: A Census of Cells and Circuits in the Aging Brain (R01 Clinical Trial Not Allowed)
Previous opportunity: Tribal College Research Area of Expertise
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DA 19 014
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DA 19 014) also looked into and applied for these:
Funding Opportunity |
---|
Responding to Opioid Use Disorders (OUD) in Tribal Communities in the Context of SAMHSA and CDC Funding (R61/R33 - Clinical Trials Optional) Apply for RFA DA 19 013 Funding Number: RFA DA 19 013 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional) Apply for PA 18 932 Funding Number: PA 18 932 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Administrative Supplements to Cancer Center Support Grants to Strengthen NCI-Supported Community Outreach Capacity through Community Health Educators of the National Outreach Network (Admin Suppl - Clinical Trial Not Allowed) Apply for PAR 18 931 Funding Number: PAR 18 931 Agency: National Institutes of Health Category: Education, Health Funding Amount: $125,000 |
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed) Apply for PAR 18 947 Funding Number: PAR 18 947 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
Biobehavioral Basis of Chronic Pain (R21 Clinical Trial Optional) Apply for PA 18 943 Funding Number: PA 18 943 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
Biobehavioral Basis of Chronic Pain (R01 Clinical Trial Optional) Apply for PA 18 944 Funding Number: PA 18 944 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R21 Clinical Trial Optional) Apply for PA 18 946 Funding Number: PA 18 946 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R01 Clinical Trial Optional) Apply for PA 18 945 Funding Number: PA 18 945 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R21 Clinical Trial Not Allowed) Apply for PAR 19 019 Funding Number: PAR 19 019 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R01 Clinical Trial Not Allowed) Apply for PAR 19 018 Funding Number: PAR 19 018 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Addressing Caregiver Symptoms through Technological Tools (R01 Clinical Trial Optional) Apply for PA 19 023 Funding Number: PA 19 023 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Addressing Caregiver Symptoms through Technological Tools (R21 Clinical Trial Optional) Apply for PA 19 024 Funding Number: PA 19 024 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R43/R44 Clinical Trial Not Allowed) Apply for PA 19 034 Funding Number: PA 19 034 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R41/R42 Clinical Trial Not Allowed) Apply for PA 19 033 Funding Number: PA 19 033 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Promoting Research on Music and Health: Fundamentals and Applications (R01 Clinical Trials Optional) Apply for RFA NS 19 008 Funding Number: RFA NS 19 008 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R01 Clinical Trial Optional) Apply for PAR 19 045 Funding Number: PAR 19 045 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R21- Clinical Trial Optional) Apply for PAR 19 044 Funding Number: PAR 19 044 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS)(UG3/UH3 Clinical Trial Required) Apply for RFA CA 19 018 Funding Number: RFA CA 19 018 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
Strategies to Provide Culturally Tailored Palliative and End-of-Life Care for Seriously Ill American Indian and Alaska Native Individuals (R21 Clinical Trial Optional) Apply for PAR 19 058 Funding Number: PAR 19 058 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
Strategies to Provide Culturally Tailored Palliative and End-of-Life Care for Seriously Ill American Indian and Alaska Native Individuals (R01 Clinical Trial Optional) Apply for PAR 19 057 Funding Number: PAR 19 057 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 19 014", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.